SAN FRANCISCO, May 24, 2017 /PRNewswire/ — OrphoMed, Inc., a clinical stage biopharmaceutical company developing first-in-class dimer therapies, today announced the completion of a…
May 24, 2017 at 04:33PM
from
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Wednesday, May 24, 2017
OrphoMed Secures $39 Million Series A Financing Round
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment